RTW Biotech Opportunities invests in Alesta Therapeutics’ €65 million series A round
LONDON: RTW Biotech Opportunities Ltd, a London Stock Exchange-listed investment company focusing on high-growth potential assets in the life sciences sector, has announced a new...